Rapid Micro Biosystems, Inc. (RPID) stock
RPIDNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 7/3057% below fair value
$0.65−0.02 (-2.98%)
Close on Nov 13, 2026Market cap $32.65MP/E –Yield –
Rapid Micro Biosystems cash
Cash and short-term investments held at the end of each period.
Rapid Micro Biosystems's cash was $19.77M at Jun 30, 2026. For fiscal 2025 it was $38.30M, down 25.1% from the year before. The highest annual figure on record is $193.78M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $38.30M | -25.1% |
| FY2024 | Dec 31, 2024 | $51.10M | -44.7% |
| FY2023 | Dec 31, 2023 | $92.34M | -15.2% |
| FY2022 | Dec 31, 2022 | $108.93M | -43.8% |
| FY2021 | Dec 31, 2021 | $193.78M | +328.9% |
| FY2020 | Dec 31, 2020 | $45.18M | +258.2% |
| FY2019 | Dec 31, 2019 | $12.61M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $19.77M | -37.3% |
| Q1 FY2026 | Mar 31, 2026 | $22.95M | -45.4% |
| Q4 FY2025 | Dec 31, 2025 | $38.30M | -25.1% |
| Q3 FY2025 | Sep 30, 2025 | $41.25M | -32.5% |
| Q2 FY2025 | Jun 30, 2025 | $31.54M | -54.7% |
| Q1 FY2025 | Mar 31, 2025 | $42.04M | -47.3% |
| Q4 FY2024 | Dec 31, 2024 | $51.10M | -44.7% |
| Q3 FY2024 | Sep 30, 2024 | $61.12M | -31.8% |
| Q2 FY2024 | Jun 30, 2024 | $69.67M | -34.5% |
| Q1 FY2024 | Mar 31, 2024 | $79.82M | -20.2% |
| Q4 FY2023 | Dec 31, 2023 | $92.34M | -15.2% |
| Q3 FY2023 | Sep 30, 2023 | $89.67M | -22.1% |
| Q2 FY2023 | Jun 30, 2023 | $106.36M | -26.3% |
| Q1 FY2023 | Mar 31, 2023 | $99.97M | -38.5% |
| Q4 FY2022 | Dec 31, 2022 | $108.93M | -43.8% |
| Q3 FY2022 | Sep 30, 2022 | $115.18M | -47.6% |
| Q2 FY2022 | Jun 30, 2022 | $144.38M | +43.9% |
| Q1 FY2022 | Mar 31, 2022 | $162.52M | +49.5% |
| Q4 FY2021 | Dec 31, 2021 | $193.78M | +328.9% |
| Q3 FY2021 | Sep 30, 2021 | $219.87M | +764.8% |
| Q2 FY2021 | Jun 30, 2021 | $100.33M | +191.6% |
| Q1 FY2021 | Mar 31, 2021 | $108.74M | +762.2% |
| Q4 FY2020 | Dec 31, 2020 | $45.18M | – |
| Q3 FY2020 | Sep 30, 2020 | $25.43M | – |
| Q2 FY2020 | Jun 30, 2020 | $34.41M | – |
| Q4 FY2019 | Dec 31, 2019 | $12.61M | – |
See a number that looks wrong?